1012343-72-4 Usage
Uses
Used in Pharmaceutical Industry:
4-(3-Bromoimidazo[1,2-b]pyridazin-6-yl)morpholine is used as a potential drug candidate for the development of new medications due to its bioactive properties. Its unique chemical structure allows for exploration in various therapeutic areas, with the aim of discovering novel treatments for a range of diseases and conditions.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 4-(3-Bromoimidazo[1,2-b]pyridazin-6-yl)morpholine serves as a valuable compound for research purposes. It is utilized in the design and synthesis of new chemical entities, with the goal of enhancing drug efficacy, selectivity, and safety. Its potential applications may extend to various therapeutic targets and pathways, contributing to the advancement of pharmaceutical science.
Used in Drug Discovery and Development:
4-(3-Bromoimidazo[1,2-b]pyridazin-6-yl)morpholine is employed in drug discovery and development processes to identify and optimize lead compounds. Its unique structural features make it a candidate for further modification and improvement, with the potential to yield new drugs with enhanced pharmacological properties. 4-(3-Bromoimidazo[1,2-b]pyridazin-6-yl)morpholine plays a crucial role in the iterative process of drug optimization, where its properties are fine-tuned to achieve the desired therapeutic effects.
Used in Chemical Synthesis and Modification:
In chemical synthesis, 4-(3-Bromoimidazo[1,2-b]pyridazin-6-yl)morpholine is used as a building block or intermediate in the preparation of more complex molecules. Its reactivity and functional groups allow for various chemical modifications, enabling the creation of diverse chemical entities with potential applications in pharmaceuticals. 4-(3-Bromoimidazo[1,2-b]pyridazin-6-yl)morpholine's versatility in synthesis contributes to the exploration of new drug candidates and the expansion of the chemical space available for drug discovery.
Check Digit Verification of cas no
The CAS Registry Mumber 1012343-72-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,1,2,3,4 and 3 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1012343-72:
(9*1)+(8*0)+(7*1)+(6*2)+(5*3)+(4*4)+(3*3)+(2*7)+(1*2)=84
84 % 10 = 4
So 1012343-72-4 is a valid CAS Registry Number.
1012343-72-4Relevant articles and documents
MODULATORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE
-
Page/Page column 18, (2011/02/18)
The present invention relates to modulators of IRAK kinase and provides compositions comprising such modulators, as well as methods therewith for treating conditions or diseases mediated by or associated with IRAK kinase.
6-AMINOIMIDAZO[1,2-b]PYRIDAZINE ANALOGS AS RHO KINASE INHIBITORS FOR THE TREATMENT OF RHO KINASE-MEDIATED DISEASES AND CONDITIONS
-
Page/Page column 7, (2008/12/06)
Methods for using 6-aminoimidazo[1,2-b]pyridazine analogs are disclosed herein to treat rho kinase-mediated diseases or rho kinase-mediated conditions, including controlling intraocular pressure and treating glaucoma, are disclosed. Ophthalmic pharmaceutical compositions useful in the treatment of eye diseases such as glaucoma, and additionally useful for controlling intraocular pressure, the compositions comprising an effective amount of 6-aminoimidazo[1,2-b]pyridazine analogs, are disclosed herein.
